Stille AB (STIL.ST)
SEK 182.0
(-2.15%)
SEK 182.0
(-2.15%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 38.06 Million SEK | -34.14% |
| 2022 | 57.8 Million SEK | -15.34% |
| 2021 | 68.27 Million SEK | 215.56% |
| 2020 | 21.63 Million SEK | -2.62% |
| 2019 | 22.21 Million SEK | 8858.06% |
| 2018 | 248 Thousand SEK | -83.76% |
| 2017 | 1.52 Million SEK | 23.44% |
| 2016 | 1.23 Million SEK | 32.73% |
| 2015 | 932 Thousand SEK | -60.58% |
| 2014 | 2.36 Million SEK | 277.64% |
| 2013 | 626 Thousand SEK | -17.31% |
| 2012 | 757 Thousand SEK | -34.74% |
| 2011 | 1.16 Million SEK | 10.37% |
| 2010 | 1.05 Million SEK | -61.77% |
| 2009 | 2.74 Million SEK | 621.52% |
| 2008 | 381 Thousand SEK | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q3 | - SEK | 0.0% |
| 2024 Q2 | - SEK | 0.0% |
| 2024 Q1 | 175.16 Million SEK | -100.0% |
| 2023 Q3 | 115.02 Million SEK | -0.78% |
| 2023 Q1 | 106.08 Million SEK | 83.53% |
| 2023 Q4 | 38.06 Million SEK | -66.91% |
| 2023 Q2 | 115.92 Million SEK | 9.28% |
| 2023 FY | 38.06 Million SEK | -34.14% |
| 2022 Q2 | 113.08 Million SEK | -1.36% |
| 2022 Q3 | 111.91 Million SEK | -1.04% |
| 2022 Q4 | 57.8 Million SEK | -48.35% |
| 2022 Q1 | 114.64 Million SEK | 67.93% |
| 2022 FY | 57.8 Million SEK | -15.34% |
| 2021 FY | 68.27 Million SEK | 215.56% |
| 2021 Q1 | 30.43 Million SEK | 40.68% |
| 2021 Q2 | 29.56 Million SEK | -2.87% |
| 2021 Q3 | 104.09 Million SEK | 252.11% |
| 2021 Q4 | 68.27 Million SEK | -34.42% |
| 2020 FY | 21.63 Million SEK | -2.62% |
| 2020 Q4 | 21.63 Million SEK | -11.97% |
| 2020 Q3 | 24.57 Million SEK | -5.33% |
| 2020 Q2 | 25.96 Million SEK | 0.58% |
| 2020 Q1 | 25.81 Million SEK | 16.19% |
| 2019 Q1 | - SEK | -100.0% |
| 2019 Q3 | - SEK | 0.0% |
| 2019 Q4 | 22.21 Million SEK | 0.0% |
| 2019 Q2 | - SEK | 0.0% |
| 2019 FY | 22.21 Million SEK | 8858.06% |
| 2018 Q2 | - SEK | 0.0% |
| 2018 FY | 248 Thousand SEK | -83.76% |
| 2018 Q4 | 248 Thousand SEK | 0.0% |
| 2018 Q3 | - SEK | 0.0% |
| 2018 Q1 | - SEK | -100.0% |
| 2017 Q3 | - SEK | 0.0% |
| 2017 Q2 | - SEK | 0.0% |
| 2017 Q1 | - SEK | -100.0% |
| 2017 FY | 1.52 Million SEK | 23.44% |
| 2017 Q4 | 1.52 Million SEK | 0.0% |
| 2016 Q2 | - SEK | 0.0% |
| 2016 Q1 | - SEK | -100.0% |
| 2016 FY | 1.23 Million SEK | 32.73% |
| 2016 Q4 | 1.23 Million SEK | 0.0% |
| 2016 Q3 | - SEK | 0.0% |
| 2015 Q2 | 2.03 Million SEK | -11.8% |
| 2015 Q1 | 2.3 Million SEK | -2.45% |
| 2015 FY | 932 Thousand SEK | -60.58% |
| 2015 Q4 | 932 Thousand SEK | -53.38% |
| 2015 Q3 | 1.99 Million SEK | -1.72% |
| 2014 Q3 | 2.71 Million SEK | 499.12% |
| 2014 Q2 | 453 Thousand SEK | -25.86% |
| 2014 Q1 | 611 Thousand SEK | -2.4% |
| 2014 FY | 2.36 Million SEK | 277.64% |
| 2014 Q4 | 2.36 Million SEK | -12.9% |
| 2013 Q2 | 830 Thousand SEK | -23.29% |
| 2013 Q1 | 1.08 Million SEK | 42.93% |
| 2013 FY | 626 Thousand SEK | -17.31% |
| 2013 Q3 | 730 Thousand SEK | -12.05% |
| 2013 Q4 | 626 Thousand SEK | -14.25% |
| 2012 Q2 | 627 Thousand SEK | -34.0% |
| 2012 Q1 | 950 Thousand SEK | -18.1% |
| 2012 Q3 | 1.04 Million SEK | 66.35% |
| 2012 Q4 | 757 Thousand SEK | -27.42% |
| 2012 FY | 757 Thousand SEK | -34.74% |
| 2011 Q2 | 1.2 Million SEK | -13.72% |
| 2011 Q1 | 1.39 Million SEK | 33.11% |
| 2011 FY | 1.16 Million SEK | 10.37% |
| 2011 Q3 | 1.36 Million SEK | 13.42% |
| 2011 Q4 | 1.16 Million SEK | -15.27% |
| 2010 Q1 | 2.01 Million SEK | -26.66% |
| 2010 FY | 1.05 Million SEK | -61.77% |
| 2010 Q4 | 1.05 Million SEK | 63.45% |
| 2010 Q3 | 643 Thousand SEK | -50.95% |
| 2010 Q2 | 1.31 Million SEK | -34.97% |
| 2009 FY | 2.74 Million SEK | 621.52% |
| 2009 Q4 | 2.74 Million SEK | 0.0% |
| 2009 Q2 | 2.5 Million SEK | -5.33% |
| 2009 Q1 | 2.64 Million SEK | 0.0% |
| 2008 FY | 381 Thousand SEK | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Acarix AB (publ) | - SEK | -Infinity% |
| ADDvise Group AB (publ) | 1.45 Billion SEK | 97.387% |
| ADDvise Group AB (publ) | 1.45 Billion SEK | 97.387% |
| Arcoma AB | 1.92 Million SEK | -1875.402% |
| Bactiguard Holding AB (publ) | 42.3 Million SEK | 10.022% |
| BICO Group AB (publ) | 1.75 Billion SEK | 97.831% |
| Boule Diagnostics AB (publ) | 57.7 Million SEK | 34.028% |
| CellaVision AB (publ) | 28.66 Million SEK | -32.801% |
| Clinical Laserthermia Systems AB (publ) | 223 Thousand SEK | -16969.955% |
| Chordate Medical Holding AB (publ) | - SEK | -Infinity% |
| C-Rad AB (publ) | 1.75 Million SEK | -2071.477% |
| Duearity AB (publ) | 2.94 Million SEK | -1194.762% |
| Dignitana AB (publ) | 6.07 Million SEK | -526.395% |
| Episurf Medical AB (publ) | 2.3 Million SEK | -1555.043% |
| Getinge AB (publ) | 3.9 Billion SEK | 99.025% |
| Scandinavian Real Heart AB (Publ) | 6.35 Million SEK | -499.189% |
| Iconovo AB (publ) | 4.9 Million SEK | -675.765% |
| Integrum AB (publ) | 4.84 Million SEK | -685.749% |
| Luxbright AB (publ) | 206.02 Thousand SEK | -18376.488% |
| Mentice AB (publ) | 2.14 Million SEK | -1675.466% |
| OssDsign AB (publ) | 214 Thousand SEK | -17687.85% |
| Paxman AB (publ) | 2.53 Million SEK | -1403.397% |
| Promimic AB (publ) | - SEK | -Infinity% |
| Qlife Holding AB (publ) | 3 Million SEK | -1167.177% |
| SciBase Holding AB (publ) | 4.17 Million SEK | -810.888% |
| ScandiDos AB (publ) | - SEK | -Infinity% |
| Sectra AB (publ) | 19.2 Million SEK | -98.219% |
| Sedana Medical AB (publ) | 1.01 Million SEK | -3661.462% |
| Senzime AB (publ) | 8.57 Million SEK | -343.763% |
| SpectraCure AB (publ) | 4.39 Million SEK | -765.727% |
| Vitrolife AB (publ) | 1.87 Billion SEK | 97.97% |
| Xvivo Perfusion AB (publ) | 21.16 Million SEK | -79.82% |